Cite
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.
MLA
Avouac, J., et al. “European League Against Rheumatism (EULAR) Scleroderma Trial and Research Group (EUSTAR) Recommendations for the Treatment of Systemic Sclerosis: Methods of Elaboration and Results of Systematic Literature Research.” Annals of the Rheumatic Diseases, vol. 68, no. 5, May 2009, pp. 629–34. EBSCOhost, https://doi.org/10.1136/ard.2008.095299.
APA
Avouac, J., Kowal-Bielecka, O., Landewe, R., Chwiesko, S., Miniati, I., Czirjak, L., Clements, P., Denton, C., Farge, D., Fligelstone, K., Földvari, I., Furst, D. E., Müller-Ladner, U., Seibold, J., Silver, R. M., Takehara, K., Toth, B. G., Tyndall, A., Valentini, G., & van den Hoogen, F. (2009). European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Annals of the Rheumatic Diseases, 68(5), 629–634. https://doi.org/10.1136/ard.2008.095299
Chicago
Avouac, J, O Kowal-Bielecka, R Landewe, S Chwiesko, I Miniati, L Czirjak, P Clements, et al. 2009. “European League Against Rheumatism (EULAR) Scleroderma Trial and Research Group (EUSTAR) Recommendations for the Treatment of Systemic Sclerosis: Methods of Elaboration and Results of Systematic Literature Research.” Annals of the Rheumatic Diseases 68 (5): 629–34. doi:10.1136/ard.2008.095299.